News

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...
Migraines are one of the world's most common neurological conditions, impacting nearly 15% of people globally. Despite this ...
GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...
GLP-1 drugs like Ozempic® and Zepbound® have gained significant attention for treating both diabetes and assisting with weight loss.
See how GLP-1 drugs reduce heart and kidney complications in MGUS and diabetes—explore the clinical evidence. Keep reading!
Experts have shared their thoughts on the impacts that GLP-1 medications such as Ozempic can have on libido as a side effect ...
The Delhi High Court on Wednesday directed the Central Drugs Standard Control Organisation (CDSCO) to decide, within 3 month ...
Historically, managing type 2 diabetes in advanced chronic kidney disease (CKD) has been challenging due to a lack of therapies and increased risks for adverse events.
A study published in the Journal of Medical Toxicology by researchers at the University of Alabama at Birmingham found that ...
An Ozempic user has revealed one unexpected side effect that's 'causing issues in their relationship'. While many people are having a lot of success taking GLP-1 drugs such as Ozempic, Mounjaro and ...
Remarkable new findings about the sugar stores in neurons have unlocked an entire new method of treating Alzheimer's disease ...
Investigators examined the comparative effectiveness of SGLT2 inhibitors and GLP-1 receptor agonists in a real-world setting.